{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:33:59Z","timestamp":1790674439737,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009780","name":"Region Sk\u00e5ne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003748","name":"Svenska S\u00e4llskapet f\u00f6r Medicinsk Forskning","doi-asserted-by":"publisher","award":["P15-0017"],"award-info":[{"award-number":["P15-0017"]}],"id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["FO2016-0121"],"award-info":[{"award-number":["FO2016-0121"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["FO2018-0080"],"award-info":[{"award-number":["FO2018-0080"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2013\/03537"],"award-info":[{"award-number":["2013\/03537"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018\/02559"],"award-info":[{"award-number":["2018\/02559"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005701","name":"\u00c5hl\u00e9n-stiftelsen","doi-asserted-by":"publisher","award":["mA28\/h17"],"award-info":[{"award-number":["mA28\/h17"]}],"id":[{"id":"10.13039\/501100005701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005753","name":"Kungliga Fysiografiska S\u00e4llskapet i Lund","doi-asserted-by":"publisher","award":["2016-37869"],"award-info":[{"award-number":["2016-37869"]}],"id":[{"id":"10.13039\/501100005753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005753","name":"Kungliga Fysiografiska S\u00e4llskapet i Lund","doi-asserted-by":"publisher","award":["2018-39651"],"award-info":[{"award-number":["2018-39651"]}],"id":[{"id":"10.13039\/501100005753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003186","name":"Fredrik och Ingrid Thurings Stiftelse","doi-asserted-by":"publisher","award":["2017-00316"],"award-info":[{"award-number":["2017-00316"]}],"id":[{"id":"10.13039\/501100003186","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015318","name":"Montreal Neurological Institute and Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015318","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.psyneuen.2020.104773","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T13:39:53Z","timestamp":1591796393000},"page":"104773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Imbalance of the oxytocin-vasopressin system contributes to the neuropsychiatric phenotype in the BACHD mouse model of Huntington disease"],"prefix":"10.1016","volume":"119","author":[{"given":"Rachel Y.","family":"Cheong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Tonetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"von H\u00f6rsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5sa","family":"Peters\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2020.104773_bib0005","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.0953-8194.2004.01161.x","article-title":"Anxiety and stress responses in female oxytocin deficient mice","volume":"16","author":"Amico","year":"2004","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3233\/JHD-180293","article-title":"Clinical management of neuropsychiatric symptoms of huntington disease: expert-based consensus guidelines on agitation, anxiety, apathy, psychosis and sleep disorders","volume":"7","author":"Anderson","year":"2018","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107691","article-title":"Effects of deletion of mutant huntingtin in steroidogenic factor 1 neurons on the psychiatric and metabolic phenotype in the BACHD mouse model of huntington disease","volume":"9","author":"Baldo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2020.104773_bib0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/nan.12514","article-title":"SIRT1 is increased in affected brain regions and hypothalamic metabolic pathways are altered in Huntington disease","volume":"45","author":"Baldo","year":"2019","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0025","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fnins.2015.00335","article-title":"Oxytocin and vasopressin: linking pituitary neuropeptides and their receptors to social neurocircuits","volume":"9","author":"Baribeau","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbscr.2018.07.001","article-title":"Investigating the relationships between hypothalamic volume and measures of circadian rhythm and habitual sleep in premanifest Huntington\u2019s disease","volume":"6","author":"Bartlett","year":"2019","journal-title":"Neurobiol. Sleep Circadian Rhythms"},{"key":"10.1016\/j.psyneuen.2020.104773_bib0035","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1073\/pnas.0631699100","article-title":"An estrogen-dependent four-gene micronet regulating social recognition: a study with oxytocin and estrogen receptor-alpha and -beta knockout mice","volume":"100","author":"Choleris","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.psyneuen.2020.104773_bib0040","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.biopsych.2008.10.011","article-title":"Intranasal oxytocin increases positive communication and reduces cortisol levels during couple conflict","volume":"65","author":"Ditzen","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2020.104773_bib0045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature12518","article-title":"Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin","volume":"501","author":"Dolen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.psyneuen.2020.104773_bib0050","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S2215-0366(16)30144-4","article-title":"Changes in mental state and behaviour in Huntington\u2019s disease","volume":"3","author":"Eddy","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psyneuen.2020.104773_bib0055","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1002\/jps.23495","article-title":"Pharmacokinetics and metabolism of SRX246: a potent and selective vasopressin 1a antagonist","volume":"102","author":"Fabio","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0060","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.expneurol.2018.01.001","article-title":"Activation of NPY-Y2 receptors ameliorates disease pathology in the R6\/2 mouse and PC12 cell models of Huntington\u2019s disease","volume":"302","author":"Fatoba","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0065","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/77040","article-title":"Social amnesia in mice lacking the oxytocin gene","volume":"25","author":"Ferguson","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0070","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00401-010-0742-6","article-title":"Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses","volume":"120","author":"Gabery","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0075","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/nan.12236","article-title":"Selective loss of oxytocin and vasopressin in the hypothalamus in early Huntington disease: a case study","volume":"41","author":"Gabery","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0080","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0085","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1248\/bpb.34.1369","article-title":"Cd38 gene knockout juvenile mice: a model of oxytocin signal defects in autism","volume":"34","author":"Higashida","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0090","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cmet.2011.02.013","article-title":"Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits","volume":"13","author":"Hult","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0095","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1093\/hmg\/ddt203","article-title":"Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington\u2019s disease","volume":"22","author":"Hult Lundh","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature05526","article-title":"CD38 is critical for social behaviour by regulating oxytocin secretion","volume":"446","author":"Jin","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.psyneuen.2020.104773_bib0105","first-page":"213","article-title":"Topography of cerebral atrophy in early Huntington\u2019s disease: a voxel based morphometric MRI study","volume":"75","author":"Kassubek","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.psyneuen.2020.104773_bib0110","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1017\/S1355617717001308","article-title":"Emotion recognition correlates with social-neuropsychiatric dysfunction in huntington\u2019s disease","volume":"24","author":"Kempnich","year":"2018","journal-title":"J. Int. Neuropsychological Soc. JINS"},{"key":"10.1016\/j.psyneuen.2020.104773_bib0115","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1471-4159.2005.03035.x","article-title":"Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine-EGFP fluorescent aggregates","volume":"93","author":"Kotliarova","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0120","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00005072-199007000-00002","article-title":"Atrophy of the hypothalamic lateral tuberal nucleus in Huntington\u2019s disease","volume":"49","author":"Kremer","year":"1990","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pnpbp.2017.09.023","article-title":"Oxytocin selectively modulates brain processing of disgust in Huntington\u2019s disease gene carriers","volume":"81","author":"Labuschagne","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2020.104773_bib0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/mp.2017.27","article-title":"Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay","volume":"23","author":"Lee","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2020.104773_bib0135","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.psyneuen.2011.02.015","article-title":"A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research","volume":"36","author":"MacDonald","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2020.104773_bib0140","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1210\/en.2002-0197","article-title":"Female oxytocin-deficient mice display enhanced anxiety-related behavior","volume":"144","author":"Mantella","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.psyneuen.2020.104773_bib0145","first-page":"25","article-title":"Novel targets for Huntington\u2019s disease: future prospects","volume":"6","author":"Mason","year":"2016","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0150","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.yhbeh.2011.12.010","article-title":"The oxytocin system in drug discovery for autism: animal models and novel therapeutic strategies","volume":"61","author":"Modi","year":"2012","journal-title":"Horm. Behav."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0155","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/mds.25980","article-title":"Systematic review of pharmacological treatments for depressive symptoms in Huntington\u2019s disease","volume":"29","author":"Moulton","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0160","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.cell.2014.09.020","article-title":"Oxytocin modulates female sociosexual behavior through a specific class of prefrontal cortical interneurons","volume":"159","author":"Nakajima","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.psyneuen.2020.104773_bib0165","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41586-019-1075-9","article-title":"Oxytocin-dependent reopening of a social reward learning critical period with MDMA","volume":"569","author":"Nardou","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.psyneuen.2020.104773_bib0170","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.tins.2012.08.004","article-title":"Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors","volume":"35","author":"Neumann","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0175","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.psyneuen.2013.03.003","article-title":"Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice","volume":"38","author":"Neumann","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2020.104773_bib0180","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/hmg\/ddi004","article-title":"Orexin loss in Huntington\u2019s disease","volume":"14","author":"Petersen","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0185","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1093\/brain\/awn244","article-title":"Hypothalamic involvement in Huntington\u2019s disease: an in vivo PET study","volume":"131","author":"Politis","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.psyneuen.2020.104773_bib0190","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4155\/tde-2018-0002","article-title":"Evidence for intranasal oxytocin delivery to the brain: recent advances and future perspectives","volume":"9","author":"Quintana","year":"2018","journal-title":"Ther. Deliv."},{"issue":"3","key":"10.1016\/j.psyneuen.2020.104773_bib0195","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3233\/JHD-199003","article-title":"Huntington\u2019s disease clinical trials corner: june 2019","volume":"8","author":"Rodrigues","year":"2019","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0200","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0205","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.bbr.2007.09.034","article-title":"Reduced ultrasonic vocalizations in vasopressin 1b knockout mice","volume":"187","author":"Scattoni","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0210","doi-asserted-by":"crossref","first-page":"E8765","DOI":"10.1073\/pnas.1807962115","article-title":"Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition","volume":"115","author":"Siebzehnrubl","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.psyneuen.2020.104773_bib0215","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.nbd.2010.07.013","article-title":"Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis","volume":"40","author":"Soneson","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0220","doi-asserted-by":"crossref","first-page":"28322","DOI":"10.1038\/srep28322","article-title":"Metabolic and behavioral effects of mutant huntingtin deletion in Sim1 neurons in the BACHD mouse model of Huntington\u2019s disease","volume":"6","author":"Soylu-Kucharz","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0225","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.neuron.2019.01.039","article-title":"Huntingtin lowering strategies for disease modification in huntington\u2019s disease","volume":"101","author":"Tabrizi","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.psyneuen.2020.104773_bib0230","doi-asserted-by":"crossref","first-page":"16096","DOI":"10.1073\/pnas.0505312102","article-title":"Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice","volume":"102","author":"Takayanagi","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.psyneuen.2020.104773_bib0235","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.psyneuen.2020.104773_bib0240","first-page":"117","article-title":"Suprachiasmatic nucleus neuropeptide expression in patients with huntington\u2019s disease","volume":"36","author":"van Wamelen","year":"2013","journal-title":"Sleep"},{"key":"10.1016\/j.psyneuen.2020.104773_bib0245","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.neubiorev.2013.04.012","article-title":"Intranasal administration of oxytocin: behavioral and clinical effects, a review","volume":"37","author":"Veening","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0250","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00441-013-1607-9","article-title":"Affective communication in rodents: ultrasonic vocalizations as a tool for research on emotion and motivation","volume":"354","author":"Wohr","year":"2013","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0255","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3233\/JHD-140132","article-title":"Social behaviour is impaired in the R6\/2 mouse model of huntington\u2019s disease","volume":"4","author":"Wood","year":"2015","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0260","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.brainresbull.2007.12.007","article-title":"Increased thirst and drinking in Huntington\u2019s disease and the R6\/2 mouse","volume":"76","author":"Wood","year":"2008","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0265","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/hmg\/ddq087","article-title":"Mutant huntingtin fragment selectively suppresses Brn-2 POU domain transcription factor to mediate hypothalamic cell dysfunction","volume":"19","author":"Yamanaka","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.psyneuen.2020.104773_bib0270","doi-asserted-by":"crossref","first-page":"15426","DOI":"10.1523\/JNEUROSCI.1148-12.2012","article-title":"A novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease","volume":"32","author":"Yu-Taeger","year":"2012","journal-title":"J. Neurosci."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453020301943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453020301943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T17:10:52Z","timestamp":1759684252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453020301943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":54,"alternative-id":["S0306453020301943"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2020.104773","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imbalance of the oxytocin-vasopressin system contributes to the neuropsychiatric phenotype in the BACHD mouse model of Huntington disease","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2020.104773","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104773"}}